Kenneth T. Mills, President and CEO at REGENXBIO Inc. (RGNX), sold 29,624 shares at $37.54 ($1.1M) on 2019-08-19, disclosed to the SEC on 2019-08-21.
Open-market sale of $1.1M RGNX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.54 | 14,624 | $549K | 49.4% |
| 2 | $37.54 | 14,624 | $549K | 49.4% |
| 3 | $37.92 | 376 | $14K | 1.3% |
| Total | $37.54 avg | 29,624 | $1.1M | 100% |
| Filing → |
| RGNX | SELL | 2024-07-18 | $33K | — | Filing → |
| RGNX | SELL | 2024-05-16 | $237K | — | Filing → |
| RGNX | SELL | 2024-04-17 | $273K | — | Filing → |